Evidence map›Paper›PMID 42028535›Full record

ArticleCureus2026

Trans-Kambin Oblique Lateral Lumbar Interbody Fusion With a Low Neurostimulation Threshold and Transient Intraoperative Neuromonitoring Changes Without Postoperative Neurological Deficits.

Praveen Saxena, Hamid Abbasi, Abdul Rauf, Dominic Moore

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Praveen SaxenaSpine Surgery, Apollo Hospitals International Limited, Ahmedabad, Ahmedabad, IND.
Hamid AbbasiSpine Surgery, Avicenna Technical University (ATU) and Inspired Spine Health, Minneapolis, USA.
Abdul RaufNeurosurgery, Inspired Spine Health, Minneapolis, USA.
Dominic MooreSpine Surgery, Inspired Spine Health, Minneapolis, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Trans-Kambin oblique lateral lumbar interbody fusion (OLLIF) is a minimally invasive lumbar fusion technique that relies heavily on intraoperative neuromonitoring (IONM) to reduce the risk of neural injury. Triggered electromyography (tEMG) stimulation thresholds below 3-4 mA are traditionally considered to indicate increased neural risk; however, the clinical implications of isolated low thresholds remain incompletely defined. We report the case of a 44-year-old female who underwent L5-S1 trans-Kambin OLLIF. During probe placement, triggered EMG responses were elicited at 2 mA, indicating close proximity to neural elements. Free-run EMG remained quiet, and baseline motor evoked potentials (MEPs) and somatosensory evoked potentials (SSEPs) were stable during dilation and cage insertion. Approximately 10 minutes after final cage positioning, an ~80% reduction in left L5 MEP amplitude occurred, which persisted until extubation. Despite these transient IONM changes, post-extubation neurological examination was normal, with no motor or sensory deficits. The patient remained neurologically intact at follow-up with improvement in preoperative symptoms. This case demonstrates that isolated low neurostimulation thresholds and transient IONM changes do not inevitably predict postoperative neurological deficit, highlighting the importance of interpreting multimodal neuromonitoring in the clinical context and emphasizing that patient-specific risk-benefit analysis and surgical judgment remain paramount.

Indexed as

electromyographyintraoperative neuromonitoringlumbar spine surgeryoblique lateral lumbar interbody fusiontrans-kambin approach

Identifiers

PMID42028535
PMCPMC13102467

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.